Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-03-11 Sale | 2024-03-11 5:20 pm | X4 Pharmaceuticals Inc | XFOR | Taveras Arthur Chief Scientific Officer | 14,235 | $0.8818 | $12,552 | 234,301 (Direct) | View |
| 2024-03-11 Sale | 2024-03-11 5:20 pm | X4 Pharmaceuticals Inc | XFOR | Ragan Paula President and CEO | 49,678 | $0.8828 | $43,856 | 765,068 (Direct) | View |
| 2024-03-11 Sale | 2024-03-11 5:19 pm | X4 Pharmaceuticals Inc | XFOR | Mostafa Adam S. Chief Financial Officer | 52,500 | $0.8828 | $46,347 | 0 (Direct) | View |
| 2024-03-11 Sale | 2024-03-11 5:19 pm | X4 Pharmaceuticals Inc | XFOR | DiBiase Mary Chief Operating Officer | 15,409 | $0.882 | $13,591 | 291,752 (Direct) | View |
| 2024-02-12 Sale | 2024-02-12 5:23 pm | X4 Pharmaceuticals Inc | XFOR | DiBiase Mary Chief Operating Officer | 3,683 | $1.007 | $3,709 | 307,161 (Direct) | View |
| 2024-02-12 Sale | 2024-02-12 5:23 pm | X4 Pharmaceuticals Inc | XFOR | Taveras Arthur Chief Scientific Officer | 787 | $1.0072 | $793 | 248,536 (Direct) | View |
| 2024-02-12 Sale | 2024-02-12 5:05 pm | X4 Pharmaceuticals Inc | XFOR | Ragan Paula President and CEO | 21,695 | $1.0091 | $21,892 | 814,746 (Direct) | View |
| 2024-02-12 Sale | 2024-02-12 5:03 pm | X4 Pharmaceuticals Inc | XFOR | Mostafa Adam S. Chief Financial Officer | 27,721 | $1.0091 | $27,973 | 52,500 (Direct) | View |
| 2023-11-01 Sale | 2023-11-03 5:26 pm | X4 Pharmaceuticals Inc | XFOR | Ragan Paula President and CEO | 239,437 | $0.75833 | $181,573 | 836,441 (Direct) | View |
| 2023-11-01 Sale | 2023-11-03 4:42 pm | X4 Pharmaceuticals Inc | XFOR | Mostafa Adam S. Chief Financial Officer | 230,645 | $0.73 | $168,371 | 80,221 (Direct) | View |
| 2023-11-01 Sale | 2023-11-03 4:40 pm | X4 Pharmaceuticals Inc | XFOR | DiBiase Mary Chief Operating Officer | 67,695 | $0.73 | $49,417 | 310,844 (Direct) | View |
| 2023-11-01 Sale | 2023-11-03 4:39 pm | X4 Pharmaceuticals Inc | XFOR | Baldry Mark Chief Commercial Officer | 10,257 | $0.73 | $7,488 | 24,690 (Direct) | View |
| 2023-11-01 Sale | 2023-11-03 4:39 pm | X4 Pharmaceuticals Inc | XFOR | Taveras Arthur Chief Scientific Officer | 67,695 | $0.73 | $49,417 | 249,323 (Direct) | View |
| 2023-09-08 Sale | 2023-09-12 4:04 pm | X4 Pharmaceuticals Inc | XFOR | DiBiase Mary Chief Operating Officer | 2,642 | $1.249 | $3,300 | 147,894 (Direct) | View |
| 2023-08-18 Purchase | 2023-08-22 4:09 pm | X4 Pharmaceuticals Inc | XFOR | WYZGA MICHAEL S Director | 25,000 | $1.195 | $29,875 | 76,667 (Direct) | View |
| 2023-08-10 Sale | 2023-08-11 7:26 pm | X4 Pharmaceuticals Inc | XFOR | Stewart Murray Interim Chief Medical Officer | 130,056 | $1.06 | $137,859 | 146,504 (Direct) | View |
| 2023-06-30 Sale | 2023-07-05 4:05 pm | X4 Pharmaceuticals Inc | XFOR | DiBiase Mary Chief Operating Officer | 464 | $1.89 | $877 | 150,536 (Direct) | View |
| 2023-06-30 Sale | 2023-07-05 4:04 pm | X4 Pharmaceuticals Inc | XFOR | Mostafa Adam S. Chief Financial Officer | 2,641 | $1.89 | $4,991 | 80,221 (Direct) | View |
| 2023-06-23 Sale | 2023-06-26 4:15 pm | X4 Pharmaceuticals Inc | XFOR | DiBiase Mary Chief Operating Officer | 857 | $1.93 | $1,654 | 151,000 (Direct) | View |
| 2023-06-23 Sale | 2023-06-26 4:13 pm | X4 Pharmaceuticals Inc | XFOR | Mostafa Adam S. Chief Financial Officer | 5,417 | $1.93 | $10,455 | 82,862 (Direct) | View |
| 2023-06-23 Sale | 2023-06-26 4:11 pm | X4 Pharmaceuticals Inc | XFOR | Ragan Paula President and CEO | 6,724 | $1.92 | $12,910 | 543,797 (Direct) | View |
| 2023-06-15 Sale | 2023-06-16 4:24 pm | X4 Pharmaceuticals Inc | XFOR | DiBiase Mary Chief Operating Officer | 857 | $2.23 | $1,911 | 151,857 (Direct) | View |
| 2023-06-15 Sale | 2023-06-16 4:17 pm | X4 Pharmaceuticals Inc | XFOR | Mostafa Adam S. Chief Financial Officer | 5,417 | $2.22 | $12,026 | 88,279 (Direct) | View |
| 2023-06-15 Sale | 2023-06-16 4:15 pm | X4 Pharmaceuticals Inc | XFOR | Ragan Paula President and CEO | 6,724 | $2.23 | $14,995 | 550,521 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-02-13 Option Award(A) | 2024-02-28 5:52 pm | N/A 2034-02-13 | X4 Pharmaceuticals Inc | XFOR | Arbet-Engels Christophe Chief Medical Officer | 180,816 | $0 | 180,816 (Direct) | View |
| 2024-02-13 Option Award | 2024-02-16 5:11 pm | N/A 2034-02-13 | X4 Pharmaceuticals Inc | XFOR | Arbet-Engels Christophe Chief Medical Officer | 475,831 | $0 | 475,831 (Direct) | View |
| 2024-02-13 Option Award | 2024-02-16 5:10 pm | N/A 2034-02-13 | X4 Pharmaceuticals Inc | XFOR | Mostafa Adam S. Chief Financial Officer | 523,414 | $0 | 523,414 (Direct) | View |
| 2024-02-13 Option Award | 2024-02-16 5:09 pm | N/A 2034-02-13 | X4 Pharmaceuticals Inc | XFOR | DiBiase Mary Chief Operating Officer | 428,248 | $0 | 428,248 (Direct) | View |
| 2024-02-13 Option Award | 2024-02-16 5:09 pm | N/A 2034-02-13 | X4 Pharmaceuticals Inc | XFOR | Ragan Paula President and CEO | 1,189,578 | $0 | 1,189,578 (Direct) | View |
| 2024-02-13 Option Award | 2024-02-16 5:09 pm | N/A 2034-02-13 | X4 Pharmaceuticals Inc | XFOR | Baldry Mark Chief Commercial Officer | 523,414 | $0 | 523,414 (Direct) | View |
| 2024-02-13 Option Award | 2024-02-16 5:08 pm | N/A 2034-02-13 | X4 Pharmaceuticals Inc | XFOR | Taveras Arthur Chief Scientific Officer | 428,248 | $0 | 428,248 (Direct) | View |
| 2023-10-31 Option Award | 2023-11-02 5:04 pm | N/A N/A | X4 Pharmaceuticals Inc | XFOR | Mostafa Adam S. Chief Financial Officer | 230,645 | $0 | 310,866 (Direct) | View |
| 2023-10-31 Option Award | 2023-11-02 5:00 pm | N/A N/A | X4 Pharmaceuticals Inc | XFOR | Baldry Mark Chief Commercial Officer | 34,947 | $0 | 34,947 (Direct) | View |
| 2023-10-31 Option Award | 2023-11-02 4:59 pm | N/A N/A | X4 Pharmaceuticals Inc | XFOR | Taveras Arthur Chief Scientific Officer | 230,645 | $0 | 317,018 (Direct) | View |
| 2023-10-31 Option Award | 2023-11-02 4:58 pm | N/A N/A | X4 Pharmaceuticals Inc | XFOR | Ragan Paula President and CEO | 532,081 | $0 | 1,075,878 (Direct) | View |
| 2023-10-31 Option Award | 2023-11-02 4:55 pm | N/A N/A | X4 Pharmaceuticals Inc | XFOR | DiBiase Mary Chief Operating Officer | 230,645 | $0 | 378,539 (Direct) | View |
| 2023-10-16 Option Award | 2023-10-18 4:02 pm | N/A N/A | X4 Pharmaceuticals Inc | XFOR | Woods Keith Director | 90,000 | $0 | 90,000 (Direct) | View |
| 2023-08-31 Option Award | 2023-09-05 4:15 pm | N/A 2033-08-30 | X4 Pharmaceuticals Inc | XFOR | Arbet-Engels Christophe Chief Medical Officer | 1,250,000 | $1.28 | 1,250,000 (Direct) | View |
| 2023-08-09 Option Award | 2023-08-11 7:26 pm | N/A N/A | X4 Pharmaceuticals Inc | XFOR | Stewart Murray Interim Chief Medical Officer | 269,893 | $0 | 146,504 (Direct) | View |